Correlation of tumor contrast enhancement on cone-beam CT and tumor response after transarterial radioembolization

Abstract

Total patients (n) 46 151 Deceased patients (n) 26 104 OS (P = 0.48) 263 ± 200 days 230 ± 211 days RECIST response CR 0 (0%) 4 (4%) PR 10 (32%) 21 (21%) SD 13 (42%) 40 (41%) PD 8 (26%) 33 (34%) No follow-up 15 53 Average delivered dose (P = 0.46) 34.74 ±14.57 mCi 36.81 ± 12.26 mCi Average prescribed dose (P = 0.31) 42.02 ± 17.03 mCi 38.89 ± 13.03 mCi